JP2005126412A5 - - Google Patents

Download PDF

Info

Publication number
JP2005126412A5
JP2005126412A5 JP2004228095A JP2004228095A JP2005126412A5 JP 2005126412 A5 JP2005126412 A5 JP 2005126412A5 JP 2004228095 A JP2004228095 A JP 2004228095A JP 2004228095 A JP2004228095 A JP 2004228095A JP 2005126412 A5 JP2005126412 A5 JP 2005126412A5
Authority
JP
Japan
Prior art keywords
propolis
skin
external preparation
extracted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004228095A
Other languages
English (en)
Japanese (ja)
Other versions
JP4212052B2 (ja
JP2005126412A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2004228095A priority Critical patent/JP4212052B2/ja
Priority claimed from JP2004228095A external-priority patent/JP4212052B2/ja
Publication of JP2005126412A publication Critical patent/JP2005126412A/ja
Publication of JP2005126412A5 publication Critical patent/JP2005126412A5/ja
Application granted granted Critical
Publication of JP4212052B2 publication Critical patent/JP4212052B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004228095A 2003-10-01 2004-08-04 色素斑除去及び再発防止用皮膚外用剤 Expired - Fee Related JP4212052B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004228095A JP4212052B2 (ja) 2003-10-01 2004-08-04 色素斑除去及び再発防止用皮膚外用剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003376273 2003-10-01
JP2004228095A JP4212052B2 (ja) 2003-10-01 2004-08-04 色素斑除去及び再発防止用皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2005126412A JP2005126412A (ja) 2005-05-19
JP2005126412A5 true JP2005126412A5 (cg-RX-API-DMAC7.html) 2007-11-08
JP4212052B2 JP4212052B2 (ja) 2009-01-21

Family

ID=34656158

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004228095A Expired - Fee Related JP4212052B2 (ja) 2003-10-01 2004-08-04 色素斑除去及び再発防止用皮膚外用剤

Country Status (1)

Country Link
JP (1) JP4212052B2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2892923B1 (fr) * 2005-11-08 2009-01-16 Engelhard Lyon Sa Utilisatiion des derives de l'acide para-coumarique ou para- hydroxycinnamique dans des compositions cosmetiques ou dermatologiques.
WO2008073684A1 (en) * 2006-12-08 2008-06-19 Lipo Chemicals Inc. Composition for treating aging skin comprising a hydroxycinnamic acid such as p-coumaric acid
JP5765879B2 (ja) * 2008-08-01 2015-08-19 小林製薬株式会社 蜂の子、プロポリス、およびローヤルゼリーを含有する経口摂取用組成物
KR101168050B1 (ko) 2009-08-25 2012-07-24 서울대학교산학협력단 카페인산 페네틸에스테르를 함유하는 비만 예방용 식품 조성물 또는 비만 치료용 제약 조성물

Similar Documents

Publication Publication Date Title
JP2007523049A5 (cg-RX-API-DMAC7.html)
BRPI0413490A (pt) novos compostos
CA2515293A1 (en) Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
CY1115940T1 (el) Παραγωγα υποκατεστημενου φαινυλαλκανοϊκου οξεος και η χρηση τους για τη θεραπευτικη αντιμετωπιση αναπνευστικων ασθενειων
PL2910551T3 (pl) Związki kwasu 1,2,4-oksadiazolobenzoesowego i ich zastosowanie do supresji mutacji nonsensownych i leczenia choroby
WO2013185112A8 (en) Pharmaceutical compositions for the treatment of cftr -mediated disorders
EP1784388B8 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ATE469163T1 (de) Phosphonat prodrogen von einem analog des 2'- fluoro-2',3'-didehydro-2',3'-dideoxyadenosins als anti-hiv mittel
EA200400881A1 (ru) Азаарилпиперазины
NO20064151L (no) Nye forbindelser
NO20076019L (no) Utvortes preparat for hud
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
HUP0303347A3 (en) Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis polymorphonucleate and mononucleate cells, process for their preparation and pharmaceutical compositions containing them
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
UY27993A1 (es) Derivados de 4-pirrolidino-fenil-bencil eter
HRP20110086T1 (hr) Dha esteri i njihova upotreba u tretmanu i prevenciji kardiovaskularnih bolesti
CL2004000806A1 (es) Compuestos derivados de quinazolinas, inhibidores de quinasa p38, composicion farmaceutica, procedimiento de preparacion, utiles para tratar artritis, enfermedad de crohn, alzheimer, asma, ataque al corazon, sepsis, infarto al miocardio y otras.
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
CA2415354A1 (en) Phospholipid derivatives of valproic acid and mixtures thereof
WO2005027977A3 (en) Diclofenac compositions for the treatment of skin disorders
WO2002020090A3 (en) Pharmaceutical compositions
EP2071030A3 (en) Oligoribonucleotide or peptide nucleic acid which inhibits action of hepatitis C virus
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
JP2012097036A5 (cg-RX-API-DMAC7.html)